Unlocking Advanced PRRT Combination of PRRT and Chemo for treating Neuroendocrine Tumors
At our center we treat about to three hundred new patients of neuroendocrine tumor every year Being a tertiary care canctumor biology of looking at various cytogenetic and molecular mechanisms which govern the efficacy of PRRT on these patients of neuroendocrine tumorsl patient and we actually practice personalized medicine We may actually combine PRRT with some targeted chemotherapy to improve the efficacy We may administer some isotopes intra arterially We may use tandem therapy whereby two different radioisotopes may be used to give the maximum benefit of PRRT to patients in a particular given setting All this is possible because we work with a team of researchers who not just practice the clinical part of PRRT but are also actively involved in very sophisticated algorithms of dosimetry of tumor biology of looking at various cytogenetic and molecular mechanisms which govern the efficacy of PRRT on these patients of neuroendocrine tumors Our team includes people from medical oncology field from pathology from cytogenetics from surgical oncology So many times patients may benefit from a combination of therapy and that is the benefit which we give to every patient.
Frequently Asked Questions